Akalin H E
Hacettepe University, School of Medicine, Section of Infectious Diseases, Ankara, Turkey.
Drugs. 1995;49 Suppl 2:128-31. doi: 10.2165/00003495-199500492-00020.
Diarrhoeal diseases are still an important health problem in both developing and developed countries, and resistance to commonly used antibiotics among enteric pathogens is a major issue. Quinolones have become important agents in the treatment of diarrhoeal diseases because of their excellent in vitro activity against pathogens and their pharmacological features. In many clinical studies, they appeared to be effective in the treatment of shigellosis and the prevention and treatment of diarrhoea in travellers. Several studies have demonstrated that single-dose therapy with these agents is sufficient in many cases. Their role in the treatment of acute salmonellosis is still controversial, because of their lack of efficacy in eliminating salmonella from the faeces.
腹泻病在发展中国家和发达国家仍然是一个重要的健康问题,肠道病原体对常用抗生素的耐药性是一个主要问题。喹诺酮类药物因其对病原体出色的体外活性及其药理学特性,已成为治疗腹泻病的重要药物。在许多临床研究中,它们似乎对治疗志贺氏菌病以及预防和治疗旅行者腹泻有效。多项研究表明,在许多情况下单剂量使用这些药物就足够了。它们在治疗急性沙门氏菌病中的作用仍存在争议,因为它们在清除粪便中的沙门氏菌方面缺乏疗效。